EV Biologics, Inc. (YECO)

Market Cap	153.38K -98.1%
Revenue (ttm)	9.47M -70.5%
Net Income	-551.58K
EPS	-0.23
Shares Out	10.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,900
Average Volume	7,227
Open	0.02087
Previous Close	n/a
Day's Range	0.0150 - 0.02087
52-Week Range	0.0131 - 0.1056
Beta	0.64
RSI	37.49
Earnings Date	n/a

About EV Biologics

Yulong Eco-Materials Limited, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: YECO

Financial Performance

In 2017, EV Biologics's revenue was $9.47 million, a decrease of -0.34% compared to the previous year's $9.51 million. Losses were -$551,581, -92.58% less than in 2017.